Pharmacotherapy with botulinum toxin: Harnessing nature's most potent neurotoxin

被引:17
作者
Bell, MS
Vermeulen, LC
Sperling, KB
机构
[1] Univ Wisconsin Hosp & Clin, Ctr Drug Policy, Madison, WI 53792 USA
[2] Valley Childrens Hosp, Madera, CA USA
[3] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA
[4] Univ Wisconsin, Sch Med, Madison, WI 53706 USA
来源
PHARMACOTHERAPY | 2000年 / 20卷 / 09期
关键词
D O I
10.1592/phco.20.13.1079.35040
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Botulinum toxin (BTX), a potent biologic neurotoxin, commonly is associated with lethal outbreaks of food poisoning; however, it also plays a role as a therapeutic agent. Since the 1970s physicians have investigated BTX therapy in patients with neurologic disorders. The number of applications greatly expanded over the years to include certain focal dystonias (blepharospasm, torticollis, laryngeal dystonias, writer's cramp), strabismus, and a wide variety of other indications (gastrointestinal disorders, cosmetic wrinkle correction, spasticity, hyperhidrosis). BTX's safety and efficacy are reviewed.
引用
收藏
页码:1079 / 1091
页数:13
相关论文
共 143 条
[11]   BOTULINUM TOXIN TREATMENT IN SPASMODIC TORTICOLLIS [J].
BLACKIE, JD ;
LEES, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (08) :640-643
[12]   LARYNGEAL DYSTONIA - A SERIES WITH BOTULINUM TOXIN THERAPY [J].
BLITZER, A ;
BRIN, MF .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1991, 100 (02) :85-89
[13]   BOTULINUM TOXIN INJECTION FOR THE TREATMENT OF OROMANDIBULAR DYSTONIA [J].
BLITZER, A ;
GREENE, PE ;
BRIN, MF ;
FAHN, S .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1989, 98 (02) :93-97
[14]   Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia [J].
Brashear, A ;
Lew, MF ;
Dykstra, DD ;
Comella, CL ;
Factor, SA ;
Rodnitzky, RL ;
Trosch, R ;
Singer, C ;
Brin, MF ;
Murray, JJ ;
Wallace, JD ;
Willmer-Hulme, A ;
Koller, M .
NEUROLOGY, 1999, 53 (07) :1439-1446
[15]  
Brin M F, 1998, Adv Neurol, V78, P237
[16]   LOCALIZED INJECTIONS OF BOTULINUM TOXIN FOR THE TREATMENT OF FOCAL DYSTONIA AND HEMIFACIAL SPASM [J].
BRIN, MF ;
FAHN, S ;
MOSKOWITZ, C ;
FRIEDMAN, A ;
SHALE, HM ;
GREENE, PE ;
BLITZER, A ;
LIST, T ;
LANGE, D ;
LOVELACE, RE ;
MCMAHON, D .
MOVEMENT DISORDERS, 1987, 2 (04) :237-254
[17]   Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia [J].
Brin, MF ;
Lew, MF ;
Adler, CH ;
Comella, CL ;
Factor, SA ;
Jankovic, J ;
O'Brien, C ;
Murray, JJ ;
Wallace, JD ;
Willmer-Hulme, A ;
Koller, M .
NEUROLOGY, 1999, 53 (07) :1431-1438
[18]   A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure [J].
Brisinda, G ;
Maria, G ;
Bentivoglio, AR ;
Cassetta, E ;
Gui, D ;
Albanese, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (02) :65-69
[19]  
Bryce GE, 1998, J OTOLARYNGOL, V27, P213
[20]   BOTULINUM TOXIN AND SWEATING [J].
BUSHARA, KO ;
PARK, DM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (11) :1437-1438